Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Statements of Cash Flows

v3.22.2
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 02, 2022
Jul. 03, 2021
Cash Flows from Operating Activities:    
Net Loss $ (14,111) $ (20,008)
Adjustments to Reconcile Net Loss to Cash Flows from Operating Activities:    
Depreciation and Amortization 14,088 14,879
Provisions for Non-Cash Losses on Inventory and Receivables 677 2,145
Equity-based Compensation Expense 3,721 3,701
Non-Cash Accrued 401K Contribution 2,197 0
Deferred Tax Benefit 0 (153)
Operating Lease Non-Cash Expense 2,928 2,343
Net Gain on Sale of Business, Before Taxes (11,284) 0
Contingent Consideration Liability Fair Value Adjustment 0 (2,200)
Other 1,320 2,105
Cash Flows from Changes in Operating Assets and Liabilities:    
Accounts Receivable (11,449) (5,281)
Inventories (19,293) 720
Accounts Payable 11,660 4,210
Accrued Expenses (458) (946)
Other Current Assets and Liabilities (3,030) (70)
Customer Advance Payments and Deferred Revenue (389) (927)
Income Taxes 16,909 (51)
Operating Lease Liabilities (3,601) (2,606)
Supplemental Retirement Plan and Other Liabilities (215) (199)
Cash Flows from Operating Activities (10,330) (2,338)
Cash Flows from Investing Activities:    
Proceeds from Sale of Business and Assets 21,977 0
Capital Expenditures (2,493) (3,566)
Cash Flows from Investing Activities 19,484 (3,566)
Cash Flows from Financing Activities:    
Proceeds from Long-term Debt 52,625 5,000
Principal Payments on Long-term Debt (79,625) (5,000)
Stock Award Activity 104 (59)
Finance Lease Principal Payments (55) (854)
Debt Acquisition Costs (771) 0
Cash Flows from Financing Activities (27,722) (913)
Effect of Exchange Rates on Cash (505) (8)
Decrease in Cash and Cash Equivalents (19,073) (6,825)
Cash and Cash Equivalents at Beginning of Period 29,757 40,412
Cash and Cash Equivalents at End of Period $ 10,684 $ 33,587